← Back to Search

eNav Toolkit for Colorectal Cancer Screening

N/A
Waitlist Available
Led By Sarah Miller, PsyD
Research Sponsored by Icahn School of Medicine at Mount Sinai
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Unable to provide informed consent
Timeline
Screening 3 weeks
Treatment Varies
Follow Up end of study, at 6 months

Summary

This trial aims to test how effective a digital navigation tool called eNav is in increasing the number of patients getting screened for colorectal cancer. The tool includes a website with information and support, as well

Who is the study for?
This trial is for patients at federally qualified health centers who need colorectal cancer screening. There are no specific inclusion or exclusion criteria provided, so it's likely open to a broad range of individuals who require screening.
What is being tested?
The study is testing the eNav Toolkit—a digital tool with a website and text messaging support designed to increase colorectal cancer screening rates among patients. It provides information, motivation, decision aid, and reminders.
What are the potential side effects?
Since this trial involves a digital navigation tool rather than medication or medical procedures, there are no traditional side effects. However, users may experience issues related to technology use such as privacy concerns or receiving unwanted communications.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I am unable to understand and give consent for treatment.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~end of study, at 6 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and end of study, at 6 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Colorectal Cancer (CRC) Screening completion
Secondary study objectives
Adherence to follow up recommendations
Number of participants who complete screening tests with adequate quality
Number of participants who complete the screening test with inadequate preparation
+1 more

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: eNav interventionExperimental Treatment1 Intervention
Subjects assigned to this arm will receive a link to the eNav website.
Group II: Usual Care GroupPlacebo Group1 Intervention
Subjects assigned to this arm will not receive the link to the website and will receive standard clinical care.

Find a Location

Who is running the clinical trial?

The Institute for Family HealthOTHER
5 Previous Clinical Trials
2,661 Total Patients Enrolled
Icahn School of Medicine at Mount SinaiLead Sponsor
903 Previous Clinical Trials
541,367 Total Patients Enrolled
1 Trials studying Colorectal Cancer Screening
386 Patients Enrolled for Colorectal Cancer Screening
National Cancer Institute (NCI)NIH
13,916 Previous Clinical Trials
41,011,427 Total Patients Enrolled
9 Trials studying Colorectal Cancer Screening
4,311 Patients Enrolled for Colorectal Cancer Screening
~262 spots leftby Jun 2026
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top